DCTH

Delcath Systems Inc (DCTH)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 382.7M
P/E Ratio
121.56
Revenue (TTM)
$ 70.24M
Volume
0
52W High
$ 18.23
52W Low
$ 8.08
Dividend Yield
0.00%
Beta
0.82

Technicals

50-Day MA
11.6774
200-Day MA
12.9223
52 Week High
18.23
52 Week Low
8.08

About DCTH

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Employees
96
Headquarters
New York, NY
CEO
Mr. Gerard J. Michel MBA, MS

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg